heart-1006 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Lilly begins dosing in cardiovascular outcomes trial of tirzepatide

The trial will include type 2 diabetes patients with atherosclerotic cardiovascular disease. Credit: StockSnap from Pixabay.